Identifying and addressing safety signals in clinical trials

N Engl J Med. 2008 Sep 25;359(13):1400-2. doi: 10.1056/NEJMe0807372. Epub 2008 Sep 3.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anticholesteremic Agents / adverse effects*
  • Anticholesteremic Agents / therapeutic use
  • Aortic Valve Stenosis / drug therapy*
  • Azetidines / adverse effects*
  • Azetidines / therapeutic use
  • Disease Progression
  • Drug Therapy, Combination
  • Ezetimibe
  • Humans
  • Incidence
  • Neoplasms / chemically induced*
  • Neoplasms / mortality
  • Randomized Controlled Trials as Topic
  • Risk
  • Simvastatin / adverse effects*
  • Simvastatin / therapeutic use

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Simvastatin
  • Ezetimibe